Company News
Company News
Read more
AgelessRx Launches Pilot Post-COVID Clinical Trial
Former ARX CMO Dr. Zalzala introduces new post-COVID-19 pilot study and shares how LDN and NAD+ may help with post-COVID-19 Syndrome.
Company News
Read more
Qalytude is Now AgelessRx
To further connect with broader audiences and continue the fight against age-related diseases, we are changing our name to AgelessRx.